FDA Plans for Expedited Licensure Approval of GSK’s Autism Drug
On Sept. 22, 2025, the U.S. Food and Drug Administration (FDA), in collaboration with the British pharmaceutical company GSK plc, announced plans to fast-track licensure of leucovorin calcium tablets. The drug, which GSK calls Wellcovorin, has long been used to treat anemia and counteract the effects of chemotherapy, The FDA will approve it for use […]
Prevalence of Autism Up Around the World
A new report published in the journal Autism Research found the prevalence of autism spectrum disorder (ASD) has grown to about 100 in 10,000 children—up from 62 in 10,000 children a decade ago. The figure is based on a systematic review of 71 epidemiological studies providing 99 ASD prevalence estimates from 34 countries, primarily the […]